Literature DB >> 19308408

Human cartilage glycoprotein 39--biomarker of joint damage in knee osteoarthritis.

Sandra Zivanović1, Ljiljana Petrović Rackov, Danilo Vojvodić, Dusan Vucetić.   

Abstract

Human glycoprotein of cartilage (YKL-40) synthesizes chondrocytes and synovial cells in inflammatory conditions or remodels the outer cell matrix in osteoarthritis. The aim of this study was to conduct a parallel analysis between thickness of cartilage and length of osteophytes, ultrasound indicators of joint destruction, with levels of YKL-40 in serum in patients with primary osteoarthritis. Ultrasound findings and concentration of YKL-40(ng/ml) were examined in 88 patients. The average value cartilage thickness measured on medial condyles of the femur was 1.30 +/- 0.23 mm and on lateral was 1.39 +/- 0.27 mm. Median YKL-40 in patients with shorter osteophytes was 62.0 (44.5-90) ng/ml, and with longer osteophytes was 119 (range 80-171) ng/ml (p = 0.000). YKL-40 can be a marker for the appearance of longer osteophytes (sensitivity = 79.1%; specificity = 61.9%; cut off = 75.0 ng/ml). The duration of illness is very much connected to values of YKL-40 (r = 0.651, p = 0.000). After an illness duration of five years, the concentration of YKL-40 was 83.68 +/- 33.65 ng/ml, after ten years it was 138.22 +/- 48.88 ng/ml, and after 15 and 20 years it was 209.30 +/- 79.36 ng/ml and 218.50 +/- 106.51 ng/ml, respectively. Higher concentrations of YKL-40 indicate the level of cartilage destruction and can be used for assessment of destruction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19308408      PMCID: PMC2898969          DOI: 10.1007/s00264-009-0747-8

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  21 in total

1.  Serum YKL-40 is associated with osteoarthritis and atherosclerosis in nonhuman primates.

Authors:  T C Register; C S Carlson; M R Adams
Journal:  Clin Chem       Date:  2001-12       Impact factor: 8.327

2.  Recommendations for the registration of drugs used in the treatment of osteoarthritis: an update on biochemical markers.

Authors:  E Vignon; P Garnero; P Delmas; B Avouac; P Bettica; M Boers; E Ehrich; N MacKillop; L Rovati; U Serni; T Spector; J Y Reginster
Journal:  Osteoarthritis Cartilage       Date:  2001-05       Impact factor: 6.576

3.  Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.

Authors:  P Garnero; M Piperno; E Gineyts; S Christgau; P D Delmas; E Vignon
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

4.  Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology.

Authors:  B Volck; J S Johansen; M Stoltenberg; C Garbarsch ; P A Price; M Ostergaard; K Ostergaard; P Løvgreen-Nielsen; S Sonne-Holm; I Lorenzen
Journal:  Osteoarthritis Cartilage       Date:  2001-04       Impact factor: 6.576

5.  [Observations on the increased serum levels of YKL-40 in patients with rheumatoid arthritis and osteoarthritis].

Authors:  M Morgante; M R Metelli; D Morgante
Journal:  Minerva Med       Date:  2001-06       Impact factor: 4.806

6.  Regulation of YKL-40 production by human articular chondrocytes.

Authors:  J S Johansen; T Olee; P A Price; S Hashimoto; R L Ochs; M Lotz
Journal:  Arthritis Rheum       Date:  2001-04

7.  Serum levels of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study.

Authors:  T Conrozier; M C Carlier; P Mathieu; F Colson; A L Debard; S Richard; H Favret; J Bienvenu; E Vignon
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

8.  Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis.

Authors:  Olivier Bruyere; Julien H Collette; Olivier Ethgen; Lucio C Rovati; Giampaolo Giacovelli; Yves E Henrotin; Laurence Seidel; Jean-Yves L Reginster
Journal:  J Rheumatol       Date:  2003-05       Impact factor: 4.666

9.  Ultrasonography is superior to clinical examination in the detection and localization of knee joint effusion in rheumatoid arthritis.

Authors:  David Kane; Peter V Balint; Roger D Sturrock
Journal:  J Rheumatol       Date:  2003-05       Impact factor: 4.666

Review 10.  Biological mechanisms of bone and cartilage remodelling--genomic perspective.

Authors:  F Borovecki; N Pecina-Slaus; S Vukicevic
Journal:  Int Orthop       Date:  2007-07-03       Impact factor: 3.075

View more
  10 in total

1.  Significant association of elevated concentration of plasma YKL-40 with disease severity in patients with pelvic inflammatory disease.

Authors:  Shu-Hsin Lee; Ching-Yi Lin; Po-Hui Wang; Chih-Ping Han; Shun-Fa Yang; Jinghua Tsai Chang; Meng-Chih Lee; Long-Yau Lin; Maw-Sheng Lee
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

2.  Relationship between sonographic parameters and YKL-40 levels in rheumatoid arthritis.

Authors:  Maria Kazakova; Anastas Batalov; Tanya Deneva; Nonka Mateva; Zlatimir Kolarov; Victoria Sarafian
Journal:  Rheumatol Int       Date:  2012-03-27       Impact factor: 2.631

3.  Increased expression of chitinase 3-like 1 is a prognosis marker for non-small cell lung cancer correlated with tumor angiogenesis.

Authors:  Xiao-Wei Wang; Cheng-Liang Cai; Jing-Ming Xu; Hai Jin; Zhi-Yun Xu
Journal:  Tumour Biol       Date:  2014-10-12

4.  Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.

Authors:  Jian-Ping Zhang; Hai-Xia Yuan; Wen-Tao Kong; Yujun Liu; Zong-Ming Lin; Wen-Ping Wangs; Jian-Ming Guo
Journal:  Tumour Biol       Date:  2014-08-21

5.  Theaflavins prevent cartilage degeneration via AKT/FOXO3 signaling in vitro.

Authors:  Jun Li; Jianping Zheng
Journal:  Mol Med Rep       Date:  2018-12-12       Impact factor: 2.952

6.  Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis.

Authors:  Mohammad Reza Jafari-Nakhjavani; Amir Ghorbanihaghjo; Babak Bagherzadeh-Nobari; Aida Malek-Mahdavi; Nadereh Rashtchizadeh
Journal:  Caspian J Intern Med       Date:  2019

7.  Serum and synovial fluid concentrations of interleukin-18 and interleukin-20 in patients with osteoarthritis of the knee and their correlation with other markers of inflammation and turnover of joint cartilage.

Authors:  Michał Waszczykowski; Anna Fabiś-Strobin; Igor Bednarski; Joanna Narbutt; Jarosław Fabiś
Journal:  Arch Med Sci       Date:  2020-07-03       Impact factor: 3.318

8.  Proteomic Analysis of Synovial Fibroblasts and Articular Chondrocytes Co-Cultures Reveals Valuable VIP-Modulated Inflammatory and Degradative Proteins in Osteoarthritis.

Authors:  Selene Pérez-García; Valentina Calamia; Tamara Hermida-Gómez; Irene Gutiérrez-Cañas; Mar Carrión; Raúl Villanueva-Romero; David Castro; Carmen Martínez; Yasmina Juarranz; Francisco J Blanco; Rosa P Gomariz
Journal:  Int J Mol Sci       Date:  2021-06-16       Impact factor: 6.208

9.  Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties.

Authors:  Valentina Calamia; Lucía Lourido; Patricia Fernández-Puente; Jesús Mateos; Beatriz Rocha; Eulalia Montell; Josep Vergés; Cristina Ruiz-Romero; Francisco J Blanco
Journal:  Arthritis Res Ther       Date:  2012-10-02       Impact factor: 5.156

10.  Co-Expression and Co-Localization of Cartilage Glycoproteins CHI3L1 and Lubricin in Osteoarthritic Cartilage: Morphological, Immunohistochemical and Gene Expression Profiles.

Authors:  Marta Anna Szychlinska; Francesca Maria Trovato; Michelino Di Rosa; Lucia Malaguarnera; Lidia Puzzo; Rosy Leonardi; Paola Castrogiovanni; Giuseppe Musumeci
Journal:  Int J Mol Sci       Date:  2016-03-11       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.